Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival

unknow

★ 5.0 · 53 reads

Request Code
ZLIB.IO18491037
Published
2022
Pages
1
Language
Unknown